Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
00:04
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

53rd ERA-EDTA Congress

 

21-24 May 2016 Vienna
FAQs
   
Discussion forum - 53rd ERA-EDTA Congress
    Topic - Chronic Kidney Disease. Bone disease.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
ERK1/2 SIGNALING IS A MODULATOR OF BM-MSC OSTEOGENIC DIFFERENTIATION IN HIGH-TURNOVER RENAL OSTEODYSTROPHY  Jianqing Jiang 1      5/10/2016 7:26:00 AM  
CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO TREATMENT WITH SUCROFERRIC OXYHYDROXIDE: A POST HOC ANALYSIS OF A PHASE 3 STUDY  Juergen Floege 1      5/9/2016 11:16:00 PM  
SUCROFERRIC OXYHYDROXIDE DOES NOT IMPACT THE IPTH-LOWERING EFFECTS OF ORAL VDRAS OR CINACALCET: A POST HOC ANALYSIS OF A PHASE 3 STUDY  Juergen Floege 1      5/9/2016 11:12:00 PM  
VASCULAR CALCIFICATION OF THE PUDENDAL ARTERY IS A SENTINEL FOR ELEVATED PULSE WAVE VELOCITY  Paul Jeronimo 1      5/9/2016 10:24:00 PM  
VASCULARCALCIFICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4, 5 AND 5D:RECAVAS STUDY.  JOSE LUIS GORRIZ TERUEL 1      5/9/2016 10:06:00 PM  
MINERAL METABOLISM OUTCOMES OF A TREATMENT PROTOCOL FOR CONTROLLING SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. A PROSPECTIVE COHORT STUDY.  Eva Gavela Martínez 1      5/9/2016 10:03:00 PM  
EFFECTS OF A REGIMEN BASED ON RESTRICTED CALCIUM INTAKE FROM PHOSPHATE BINDERS, LOW DOSE VITAMIN D SUPPLEMENTATION , AND PARICALCITOL, ON SURVIVAL, HOSPITALIZATION AND RENAL PROGRESSION. A PROSPECTIVE COHORT STUDY IN NON-DIALYSIS CKD PATIENTS.  Eva Gavela Martínez 1      5/9/2016 9:56:00 PM  
aKLOTHO AND FIBROBLAST GROWTH FACTOR 23 ARE NOT ASSOCIATED WITH THE DECREASE OF TUBULAR PHOSPHATE REABSORBTION IN EARLY CKD: EXPERIMENTAL AND CLINICAL STUDY  Evdokia Bogdanova 1      5/9/2016 7:35:00 PM  
THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY  Adriana Dusso 1      5/9/2016 7:00:00 PM  
FGF23, IRON STATUS AND VITAMIN D METABOLISM IN CHRONIC KIDNEY DISEASE  Isabelle Piec 1      5/9/2016 5:53:00 PM  
CHRONIC KIDNEY DISEASE DISTURBS CARDIAC CALCIUM HANDLING DUE TO HIGH FGF23 LEVELS  Melissa Verkaik 1      5/9/2016 11:54:00 AM  
TREATMENT OF PERSISTENT HYPERCALCEMIA IN KIDNEY TRANSPLANT RECIPIENTS WITH CINACALCET  Ayssegul ORUC 1      5/9/2016 11:51:00 AM  
ENDOTHELIAL DYSFUNCTION IN EXPERIMENTAL CHRONIC KIDNEY DISEASE IS CAUSED BY FGF23  Melissa Verkaik 1      5/9/2016 11:51:00 AM  
VITAMIN D DEFICIENCY AND ELEVATED PTH BUT NOT FGF-23 PREDICT ALL-CAUSE MORTALITY IN PEOPLE WITH CKD STAGE 3 IN PRIMARY CARE  Adam Shardlow 1      5/8/2016 10:23:00 PM  
ARE MEDICINAL PRODUCTS A RELEVANT SOURCE OF HIDDEN EXTRA-PHOSPHATE LOAD IN CKD PATIENTS ?  Adamasco Cupisti 1      5/8/2016 5:02:00 PM  
LOW MAGNESIUM LEVELS ARE CLOSELY RELATED WITH FGF-23 LEVELS AND ARTERIAL STIFFNESS IN HEMODIALYSIS PATIENTS  Zeynep Bal 1      5/6/2016 9:26:00 PM  
CHOLECALCIFEROL SUPPLEMENTATION IN HEMODIALYSIS: NO RISKS AND POSSIBLE NUTRITIONAL BENEFIT  MAKROUHI SONIKIAN 1      5/6/2016 8:14:00 PM  
IMPACT OF HYPERPHOSPHATEMIA CORRECTIVE THERAPY ON CARDIOVASCULAR RISK MARKER - FGF-23 IN CHRONIC KIDNEY DISEASE PATIENTS.  Yuriy Milovanov 1      5/6/2016 5:55:00 PM  
VITAMIN D RECEPTOR ACTIVATION INCREASES SERUM SCLEROSTIN IN CKD PATIENTS: A RANDOMIZED CLINICAL TRIAL  Claudia Torino 1      5/6/2016 11:47:00 AM  
SOLUBLE KLOTHO AND FIBROBLAST GROWTH FACTOR 23 LEVELS IN DIABETIC NEPHROPATHY: RELATIONSHIP WITH ARTERIAL STIFFNESS  Ayca Inci 1      5/6/2016 11:47:00 AM  
ELECTIVE PARATHYROID SURGERY IN DIALYSIS PATIENTS WITH CHRONIC RENAL FAILURE AND MORTALITY  Deborah Sylvester 1      5/5/2016 10:26:00 PM  
CALCITRIOL ALTERS THE PATHOLOGICAL PHENOTYPE ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY IN AN EXPERIMENTAL MODEL OF CHRONIC KIDNEY DISEASE  Mandy Turner 1      5/5/2016 8:22:00 PM  
BONE DISEASE CHARACTERIZATION IN A GROUP OF PREDIALYSIS PATIENTS  Ricardo Neto 1      5/5/2016 1:01:00 AM  
DOES CHOLECALCIFEROL CORRECT SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?  Cristina Capusa 1      5/4/2016 8:21:00 PM  
INFLAMMATION BUT NOT DERANGED MINERAL METABOLISM MAY EXPLAIN THE PROGRESSION OF CORONARY ARTERY CALCIFICATION IN CKD PATIENTS NOT ON DIALYSIS  Luigi Russo 1      5/3/2016 3:17:00 PM  
PHOSPHATE CONTAINING PRESCRIPTION MEDICATIONS CONTRIBUTE TO THE DAILY PHOSPHATE INTAKE IN A THIRD OF HEMODIALYSIS PATIENTS  Rachel Holden 1      5/2/2016 8:31:00 PM  
ADDITION OF SEVELAMER AND MORTALITY: THE WORLDWIDE DOPPS STUDY  Hirotaka Komaba 1      4/30/2016 2:52:00 AM  
THE RESULTS OF NONINVASIVE BONE MINERAL DENSITY STUDIES IN CHILDREN AND ADULTS WITH END-STAGE RENAL FAILURE ON HEMODIALYSIS  Abay Shepetov 1      4/17/2016 12:53:00 PM  
IRON CITRATE REDUCES HIGH PHOSPHATE-INDUCED VASCULAR CALCIFICATION BY INHIBITING APOPTOSIS  mario cozzolino 1      4/16/2016 9:17:00 AM  
       




Most viewed poster for this congress
Poster: 547
Visits: 1241
Title: COMPARISON OF PATIENT HAEMOGLOBIN OUTCOMES WITH WEEKLY IRON ADMINISTRATION VS PER SESSION IRON ADMINISTRATION IN ADULT HAEMODIALYSIS PATIENTS
Authors: Joao Fazendeiro , Ricardo Peralta, Carla Felix, Bruno Pinto, Ilidio Rodrigues, Carlos Oliveira, Anibal Ferreira, Pedro Ponce
Centre: Fresenius Medical Care Portugal

Poster most viewed in this topic
Poster: 365
Visits: 28
Title: SUCROFERRIC OXYHYDROXIDE DOES NOT IMPACT THE IPTH-LOWERING EFFECTS OF ORAL VDRAS OR CINACALCET: A POST HOC ANALYSIS OF A PHASE 3 STUDY
Authors: Jrgen Floege ,
Centre: RWTH University Hospital Aachen, Department of Nephrology and Clinical Immunology, Aachen, Germany


 






PosterSessionOnline
Logo Draft
 
Logo Cert